Propagenix Inc
Gaithersburg, MD · Founded 2013 · CIK 0001605963 · Biotech · Acquired
Domain name and backlink portfolio
propagenix.com →- Grants
- $1.0M
- 4 awards
- Sector median: 1
- Raised
- $2.3M
- 1 Form D · Apr 2014
- 149 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 22
- 10 granted · 12 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201320142015201620172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Enhancement of Conditional Reprogramming Technology for Production of Functional Human Beta-Cells | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · HLS-Applying EpiX™ technology to enable ex vivo theratyping using nasal brushing samples from CF patients | $263,235 | |
| Federal grant | Department of Health and Human Services · Phase I · HLS-Applying EpiX technology to enable ex vivo theratyping using nasal brushing samples from CF patients | $263,235 | |
| Federal grant | Department of Health and Human Services · Phase I · A Commercially Durable Biobank of Genetically Diverse and Differentiation Competent Primary Airway Progenitor Cells Validated for In Vitro Toxicology Screening | $252,131 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2365 | Biodesy LLC | — | $350K |
| 2366 | Montara Therapeutics | — | $28M |
| 2367 | VST BIO Corp | — | $29M |
| 2368 | Propagenix Inc | — | $2.3M |
| 2369 | Merida Biosciences | — | — |
| 2370 | 3D HEALTH SOLUTIONS, INC. | — | — |
| 2371 | Helicore, LLC | — | $2.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Greg BettertonDirector
- Sharon ChallbergExecutive Officer
- John KontorDirector
- Wlodek KrawiecDirector
- Edward MakerDirector
- Brian PollokDirector · Executive Officer
- David RossDirector
Patents
- Ex Vivo Proliferation Of Epithelial Cellsapplication
- Ex Vivo Proliferation Of Epithelial Cellsgranted
- Ex Vivo Proliferation Of Epithelial Cellsgranted
- Epithelial Cell Spheroids Having Exterior Apical Memrbaneapplication
- Ex Vivo Proliferation Of Epithelial Cellsgranted
- Ex Vivo Proliferation Of Epithelial Cellsgranted
- Ex Vivo Proliferation Of Epithelial Cellsgranted
- Ex Vivo Proliferation Of Epithelial Cellsgranted
- Ex Vivo Proliferation Of Epithelial Cellsgranted
- Ex Vivo Proliferation Of Epithelial Cellsgranted
- Ex Vivo Proliferation Of Epithelial Cellsgranted
- Ex Vivo Proliferation Of Epithelial Cellsgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.